EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB /D

Rebecca Mächtel, Jan-Philipp Dobert, Ute Hehr, Alexander Weiss, Matthias Kettwig, Lucia Laugwitz, Samuel Groeschel, Manuel Schmidt, Philipp Arnold, Martin Regensburger iD, Friederike Zunke iD

Annals of Clinical and Translational Neurology · 2024

DOI: 10.1002/acn3.52078 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Clinical and Translational Neurology, 2024. Verfasst von Rebecca Mächtel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany. Hauptthemen laut MEDLINE: Leukodystrophy, Globoid Cell, Cathepsin D, Galactosylceramidase, Cathepsin B. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Interdisciplinary Center for Clinical Research (IZKF) of the University Hospital of the University of Erlangen-Nuremberg, Bundesministerium für Bildung und Forschung (BMBF), Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Krabbe disease (KD) is a multisystem neurodegenerative disorder with severe disability and premature death, mostly with an infancy/childhood onset. In rare cases of late‐onset phenotypes, symptoms are often milder and difficult to diagnose. We here present a translational approach combining diagnostic and biochemical analyses of a male patient with a progressive gait disorder starting at the age of 44 years, with a final diagnosis of late‐onset KD (LOKD).

Methods

Additionally to cerebral MRI, protein structural analyses of the β‐galactocerebrosidase protein (GALC) were performed. Moreover, expression, lysosomal localization, and activities of β‐glucocerebrosidase (GCase), cathepsin B (CTSB), and cathepsin D (CTSD) were analyzed in leukocytes, fibroblasts, and lysosomes of fibroblasts.

Results

Exome sequencing revealed biallelic likely pathogenic variants: GALC exons 11–17: 33 kb deletion; exon 4: missense variant (c.334A>G, p.Thr112Ala). We detected a reduced GALC activity in leukocytes and fibroblasts. While histological KD phenotypes were absent in fibroblasts, they showed a significantly decreased activities of GCase, CTSB, and CTSD in lysosomal fractions, while expression levels were unaffected.

Interpretation

The presented LOKD case underlines the age‐dependent appearance of a mildly pathogenic GALC variant and its interplay with other lysosomal proteins. As GALC malfunction results in reduced ceramide levels, we assume this to be causative for the here described decrease in CTSB and CTSD activity, potentially leading to diminished GCase activity. Hence, we emphasize the importance of a functional interplay between the lysosomal enzymes GALC, CTSB, CTSD, and GCase, as well as between their substrates, and propose their conjoined contribution in KD pathology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukodystrophy, Globoid CellCathepsin DGalactosylceramidaseCathepsin BHumansMaleAdultParaplegiaAge of OnsetGlucosylceramidaseLysosomesFibroblasts

Stichwörter der Autor:innen

Krabbe diseasecathepsin Bcathepsin Denzymatic activitylate‐onsetβ‐glucocerebrosidase

Substanzen

Cathepsin DGalactosylceramidaseCTSD protein, humanCathepsin BCTSB protein, humanGlucosylceramidase

Autor:innen und Institutionen

  • Department of Molecular Neurology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Center for Human Genetics, Regensburg, Germany.
  • Department of Pediatrics and Pediatric Neurology, University Medical Center Göttingen, Georg August University Göttingen, Göttingen, Germany.
  • Department of Pediatric Neurology, University Children's Hospital Tübingen, Tübingen, Germany.
  • Department of Neuroradiology, FAU, Erlangen, Germany.
  • Institute of Functional and Clinical Anatomy, FAU, Erlangen, Germany.

ORCID-Profile: Martin Regensburger, Friederike Zunke

Förderung

  • Interdisciplinary Center for Clinical Research (IZKF) of the University Hospital of the University of Erlangen-Nuremberg
  • Bundesministerium für Bildung und Forschung (BMBF)
  • Deutsche Forschungsgemeinschaft
  • Michael J. Fox Foundation for Parkinson's Research

Zitieren

APA

Mächtel, R., Dobert, J. P., Hehr, U., Weiss, A., Kettwig, M., Laugwitz, L., Groeschel, S., Schmidt, M., Arnold, P., Regensburger, M., & Zunke, F. (2024). Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB /D. Annals of Clinical and Translational Neurology. https://doi.org/10.1002/acn3.52078

Vancouver

Mächtel R, Dobert JP, Hehr U, Weiss A, Kettwig M, Laugwitz L, et al. Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB /D. Annals of Clinical and Translational Neurology. 2024. doi:10.1002/acn3.52078

BibTeX
@article{Mchtel2024,
  author = {Mächtel, Rebecca and Dobert, Jan-Philipp and Hehr, Ute and Weiss, Alexander and Kettwig, Matthias and Laugwitz, Lucia and Groeschel, Samuel and Schmidt, Manuel and Arnold, Philipp and Regensburger, Martin and Zunke, Friederike},
  title = {Late‐onset Krabbe disease presenting as spastic paraplegia – implications of GCase and CTSB /D},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2024},
  doi = {10.1002/acn3.52078}
}
Kostenlos starten →